Medifocus to Present Two Posters; on Positive Clinical Results of Two Studies for the Treatment of Early-Stage and Large Breast Tumors, and an Update of Phase III Clinical Study for Large Breast Tumors

COLUMBIA, Md.--(BUSINESS WIRE)--Medifocus Inc. (OTC:MDFZF.PK and TSXV:MFS) is pleased to announce that two (2) clinical presentations of the Company’s breast cancer treatment system, the Microfocus APA-1000, will be made at the 21st Annual National Interdisciplinary Breast Center Conference , March 12-16, 2011 in Las Vegas , NV.